Manipal Health Enterprises Limited announced robust financial results for the second quarter and first half of FY27. Revenue grew by 37.3% year-on-year to ₹3,399 crore in Q2 FY27, with EBITDA rising 29.8% to ₹882 crore. For H1 FY27, revenue reached ₹6,490 crore, up 37.7%, and EBITDA increased by 28.2%. The company saw significant improvements in inpatient and outpatient volumes, occupancy rates, and Average Revenue Per Occupied Bed (ARPOB).
Manipal Hospitals Announces Strong Q2 and H1 FY27 Performance
Bengaluru, Karnataka, November 13, 2026 – Manipal Health Enterprises Limited, a leading pan-India multi-specialty hospital network, today announced its financial results for the quarter and half year ended September 30, 2026 (Q2 FY27). The company reported a strong operating performance, driven by sustained patient demand, growth in high-acuity specialties, and improved capacity utilization across its expanded network.
Key Financial Highlights for Q2 FY27
- Revenue from operations stood at ₹3,399 crore, marking a 37.3% year-on-year growth.
- EBITDA reached ₹882 crore, an increase of 29.8% year-on-year.
- EBITDA margin was 26.0% (26.8% excluding Sahyadri).
- PAT (excluding exceptional items) was ₹380 crore, up 21.6% year-on-year.
H1 FY27 Performance
- Revenue for the first half of FY27 grew to ₹6,490 crore, a 37.7% increase year-on-year.
- EBITDA increased by 28.2% to ₹1,631 crore.
- Excluding a one-off gain in H1 FY26, EBITDA growth was 29.8%.
Operational Performance and Network Expansion
In Q2 FY27, inpatient volumes grew by 35.0% to approximately 169,000, and outpatient volumes rose by 27.2% to approximately 1.74 million. Occupancy improved by 160 basis points year-on-year to 70.1%, with an average operational capacity of 7,331 beds. The network expanded with the opening of a 300-licensed-bed hospital in Electronic City, Bengaluru, increasing the total licensed bed capacity to 13,440 as of September 30, 2026.
Average Revenue Per Occupied Bed (ARPOB) stood at ₹70,600 per day. The integration of Sahyadri Hospitals, acquired on October 3, 2025, has contributed significantly to revenue and EBITDA, with its integration progressing well. High-acuity specialties like Cardiac Sciences, Oncology, and Neurosciences continue to drive momentum, showing strong year-on-year growth.
Outlook
Dilip Jose, Managing Director & CEO, Manipal Hospitals, commented, “We are pleased that our performance this quarter has been driven by volumes with more patients accessing our care and this we believe is the sustainable option for growth in care delivery. Improved capacity utilisation, particularly in high-acuity specialties continued to be a key driver while maintaining focus on strengthening our clinical capabilities, improving operational performance and building a more integrated healthcare platform.”
Source: BSE
